Infectious Bursal Disease Vaccine Market, Global Outlook and Forecast 2022-2028
Infectious Bursal Disease Vaccine is used to prevent infectious bursal disease in chickens, which is one of the main infectious diseases in the chicken industry.
This report contains market size and forecasts of Infectious Bursal Disease Vaccine in global, including the following market information:
Global Infectious Bursal Disease Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Bursal Disease Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Bursal Disease Vaccine companies in 2021 (%)
The global Infectious Bursal Disease Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Live Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Bursal Disease Vaccine include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Bursal Disease Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Bursal Disease Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Bursal Disease Vaccine Market Segment Percentages, by Type, 2021 (%)
Global Infectious Bursal Disease Vaccine Market Segment Percentages, by Application, 2021 (%)
Global Infectious Bursal Disease Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Infectious Bursal Disease Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Bursal Disease Vaccine revenues share in global market, 2021 (%)
Key companies Infectious Bursal Disease Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Bursal Disease Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Infectious Bursal Disease Vaccine in global, including the following market information:
Global Infectious Bursal Disease Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Infectious Bursal Disease Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Infectious Bursal Disease Vaccine companies in 2021 (%)
The global Infectious Bursal Disease Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Live Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Bursal Disease Vaccine include Zoetis, Merck, Elanco, Boehringer Ingelheim, Ceva, Qingdao Yibang Biological Engineering Co., Ltd., Shandong Lvdu Biological Technology Co., Ltd., Plyco Bioengineering Co., Ltd. and Ruipu Biopharmaceutical Co., Ltd. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Bursal Disease Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Bursal Disease Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Infectious Bursal Disease Vaccine Market Segment Percentages, by Type, 2021 (%)
- Live
- Inactivated
Global Infectious Bursal Disease Vaccine Market Segment Percentages, by Application, 2021 (%)
- Veterinary Pharmacy
- Online Sale
- Others
Global Infectious Bursal Disease Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Infectious Bursal Disease Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Infectious Bursal Disease Vaccine revenues share in global market, 2021 (%)
Key companies Infectious Bursal Disease Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Infectious Bursal Disease Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zoetis
- Merck
- Elanco
- Boehringer Ingelheim
- Ceva
- Qingdao Yibang Biological Engineering Co., Ltd.
- Shandong Lvdu Biological Technology Co., Ltd.
- Plyco Bioengineering Co., Ltd.
- Ruipu Biopharmaceutical Co., Ltd.
- Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Infectious Bursal Disease Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Bursal Disease Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE OVERALL MARKET SIZE
2.1 Global Infectious Bursal Disease Vaccine Market Size: 2021 VS 2028
2.2 Global Infectious Bursal Disease Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Infectious Bursal Disease Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Infectious Bursal Disease Vaccine Players in Global Market
3.2 Top Global Infectious Bursal Disease Vaccine Companies Ranked by Revenue
3.3 Global Infectious Bursal Disease Vaccine Revenue by Companies
3.4 Global Infectious Bursal Disease Vaccine Sales by Companies
3.5 Global Infectious Bursal Disease Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Infectious Bursal Disease Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Infectious Bursal Disease Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Infectious Bursal Disease Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Infectious Bursal Disease Vaccine Market Size Markets, 2021 & 2028
4.1.2 Live
4.1.3 Inactivated
4.2 By Type - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
4.2.1 By Type - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Infectious Bursal Disease Vaccine Sales & Forecasts
4.3.1 By Type - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
4.3.2 By Type - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
4.3.3 By Type - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Infectious Bursal Disease Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Bursal Disease Vaccine Market Size, 2021 & 2028
5.1.2 Veterinary Pharmacy
5.1.3 Online Sale
5.1.4 Others
5.2 By Application - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
5.2.1 By Application - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Infectious Bursal Disease Vaccine Sales & Forecasts
5.3.1 By Application - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
5.3.2 By Application - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
5.3.3 By Application - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Infectious Bursal Disease Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Bursal Disease Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
6.2.1 By Region - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Infectious Bursal Disease Vaccine Sales & Forecasts
6.3.1 By Region - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
6.3.2 By Region - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
6.3.3 By Region - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Infectious Bursal Disease Vaccine Sales, 2017-2028
6.4.3 US Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.4.4 Canada Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.4.5 Mexico Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Infectious Bursal Disease Vaccine Sales, 2017-2028
6.5.3 Germany Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.4 France Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.5 U.K. Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.6 Italy Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.7 Russia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.9 Benelux Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Infectious Bursal Disease Vaccine Sales, 2017-2028
6.6.3 China Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.4 Japan Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.5 South Korea Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.7 India Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Infectious Bursal Disease Vaccine Sales, 2017-2028
6.7.3 Brazil Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.7.4 Argentina Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, 2017-2028
6.8.3 Turkey Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.4 Israel Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.6 UAE Infectious Bursal Disease Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Zoetis
7.1.1 Zoetis Corporate Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Infectious Bursal Disease Vaccine Major Product Offerings
7.1.4 Zoetis Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Zoetis Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Infectious Bursal Disease Vaccine Major Product Offerings
7.2.4 Merck Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Infectious Bursal Disease Vaccine Major Product Offerings
7.3.4 Elanco Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Elanco Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Major Product Offerings
7.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 Ceva
7.5.1 Ceva Corporate Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Infectious Bursal Disease Vaccine Major Product Offerings
7.5.4 Ceva Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Ceva Key News
7.6 Qingdao Yibang Biological Engineering Co., Ltd.
7.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporate Summary
7.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
7.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Key News
7.7 Shandong Lvdu Biological Technology Co., Ltd.
7.7.1 Shandong Lvdu Biological Technology Co., Ltd. Corporate Summary
7.7.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
7.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Shandong Lvdu Biological Technology Co., Ltd. Key News
7.8 Plyco Bioengineering Co., Ltd.
7.8.1 Plyco Bioengineering Co., Ltd. Corporate Summary
7.8.2 Plyco Bioengineering Co., Ltd. Business Overview
7.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Plyco Bioengineering Co., Ltd. Key News
7.9 Ruipu Biopharmaceutical Co., Ltd.
7.9.1 Ruipu Biopharmaceutical Co., Ltd. Corporate Summary
7.9.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
7.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Ruipu Biopharmaceutical Co., Ltd. Key News
7.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
7.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporate Summary
7.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
7.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Key News
8 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Infectious Bursal Disease Vaccine Production Capacity, 2017-2028
8.2 Infectious Bursal Disease Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Bursal Disease Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFECTIOUS BURSAL DISEASE VACCINE SUPPLY CHAIN ANALYSIS
10.1 Infectious Bursal Disease Vaccine Industry Value Chain
10.2 Infectious Bursal Disease Vaccine Upstream Market
10.3 Infectious Bursal Disease Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Bursal Disease Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Infectious Bursal Disease Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Bursal Disease Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE OVERALL MARKET SIZE
2.1 Global Infectious Bursal Disease Vaccine Market Size: 2021 VS 2028
2.2 Global Infectious Bursal Disease Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Infectious Bursal Disease Vaccine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Infectious Bursal Disease Vaccine Players in Global Market
3.2 Top Global Infectious Bursal Disease Vaccine Companies Ranked by Revenue
3.3 Global Infectious Bursal Disease Vaccine Revenue by Companies
3.4 Global Infectious Bursal Disease Vaccine Sales by Companies
3.5 Global Infectious Bursal Disease Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Infectious Bursal Disease Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Infectious Bursal Disease Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Infectious Bursal Disease Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Infectious Bursal Disease Vaccine Market Size Markets, 2021 & 2028
4.1.2 Live
4.1.3 Inactivated
4.2 By Type - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
4.2.1 By Type - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Infectious Bursal Disease Vaccine Sales & Forecasts
4.3.1 By Type - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
4.3.2 By Type - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
4.3.3 By Type - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Infectious Bursal Disease Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Bursal Disease Vaccine Market Size, 2021 & 2028
5.1.2 Veterinary Pharmacy
5.1.3 Online Sale
5.1.4 Others
5.2 By Application - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
5.2.1 By Application - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Infectious Bursal Disease Vaccine Sales & Forecasts
5.3.1 By Application - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
5.3.2 By Application - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
5.3.3 By Application - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Infectious Bursal Disease Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Bursal Disease Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Infectious Bursal Disease Vaccine Revenue & Forecasts
6.2.1 By Region - Global Infectious Bursal Disease Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Infectious Bursal Disease Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Infectious Bursal Disease Vaccine Sales & Forecasts
6.3.1 By Region - Global Infectious Bursal Disease Vaccine Sales, 2017-2022
6.3.2 By Region - Global Infectious Bursal Disease Vaccine Sales, 2023-2028
6.3.3 By Region - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Infectious Bursal Disease Vaccine Sales, 2017-2028
6.4.3 US Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.4.4 Canada Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.4.5 Mexico Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Infectious Bursal Disease Vaccine Sales, 2017-2028
6.5.3 Germany Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.4 France Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.5 U.K. Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.6 Italy Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.7 Russia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.5.9 Benelux Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Infectious Bursal Disease Vaccine Sales, 2017-2028
6.6.3 China Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.4 Japan Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.5 South Korea Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.6.7 India Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Infectious Bursal Disease Vaccine Sales, 2017-2028
6.7.3 Brazil Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.7.4 Argentina Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, 2017-2028
6.8.3 Turkey Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.4 Israel Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Infectious Bursal Disease Vaccine Market Size, 2017-2028
6.8.6 UAE Infectious Bursal Disease Vaccine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Zoetis
7.1.1 Zoetis Corporate Summary
7.1.2 Zoetis Business Overview
7.1.3 Zoetis Infectious Bursal Disease Vaccine Major Product Offerings
7.1.4 Zoetis Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Zoetis Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Infectious Bursal Disease Vaccine Major Product Offerings
7.2.4 Merck Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Elanco
7.3.1 Elanco Corporate Summary
7.3.2 Elanco Business Overview
7.3.3 Elanco Infectious Bursal Disease Vaccine Major Product Offerings
7.3.4 Elanco Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Elanco Key News
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Corporate Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Infectious Bursal Disease Vaccine Major Product Offerings
7.4.4 Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim Key News
7.5 Ceva
7.5.1 Ceva Corporate Summary
7.5.2 Ceva Business Overview
7.5.3 Ceva Infectious Bursal Disease Vaccine Major Product Offerings
7.5.4 Ceva Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Ceva Key News
7.6 Qingdao Yibang Biological Engineering Co., Ltd.
7.6.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporate Summary
7.6.2 Qingdao Yibang Biological Engineering Co., Ltd. Business Overview
7.6.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.6.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Qingdao Yibang Biological Engineering Co., Ltd. Key News
7.7 Shandong Lvdu Biological Technology Co., Ltd.
7.7.1 Shandong Lvdu Biological Technology Co., Ltd. Corporate Summary
7.7.2 Shandong Lvdu Biological Technology Co., Ltd. Business Overview
7.7.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.7.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Shandong Lvdu Biological Technology Co., Ltd. Key News
7.8 Plyco Bioengineering Co., Ltd.
7.8.1 Plyco Bioengineering Co., Ltd. Corporate Summary
7.8.2 Plyco Bioengineering Co., Ltd. Business Overview
7.8.3 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.8.4 Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Plyco Bioengineering Co., Ltd. Key News
7.9 Ruipu Biopharmaceutical Co., Ltd.
7.9.1 Ruipu Biopharmaceutical Co., Ltd. Corporate Summary
7.9.2 Ruipu Biopharmaceutical Co., Ltd. Business Overview
7.9.3 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.9.4 Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Ruipu Biopharmaceutical Co., Ltd. Key News
7.10 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd.
7.10.1 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporate Summary
7.10.2 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Business Overview
7.10.3 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Major Product Offerings
7.10.4 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Key News
8 GLOBAL INFECTIOUS BURSAL DISEASE VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Infectious Bursal Disease Vaccine Production Capacity, 2017-2028
8.2 Infectious Bursal Disease Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Infectious Bursal Disease Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 INFECTIOUS BURSAL DISEASE VACCINE SUPPLY CHAIN ANALYSIS
10.1 Infectious Bursal Disease Vaccine Industry Value Chain
10.2 Infectious Bursal Disease Vaccine Upstream Market
10.3 Infectious Bursal Disease Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Infectious Bursal Disease Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Infectious Bursal Disease Vaccine in Global Market
Table 2. Top Infectious Bursal Disease Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Infectious Bursal Disease Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Infectious Bursal Disease Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Infectious Bursal Disease Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Infectious Bursal Disease Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Infectious Bursal Disease Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Infectious Bursal Disease Vaccine Product Type
Table 9. List of Global Tier 1 Infectious Bursal Disease Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 46. Zoetis Corporate Summary
Table 47. Zoetis Infectious Bursal Disease Vaccine Product Offerings
Table 48. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Infectious Bursal Disease Vaccine Product Offerings
Table 51. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Elanco Corporate Summary
Table 53. Elanco Infectious Bursal Disease Vaccine Product Offerings
Table 54. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Boehringer Ingelheim Corporate Summary
Table 56. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offerings
Table 57. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Ceva Corporate Summary
Table 59. Ceva Infectious Bursal Disease Vaccine Product Offerings
Table 60. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Qingdao Yibang Biological Engineering Co., Ltd. Corporate Summary
Table 62. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 63. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shandong Lvdu Biological Technology Co., Ltd. Corporate Summary
Table 65. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 66. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Plyco Bioengineering Co., Ltd. Corporate Summary
Table 68. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 69. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Ruipu Biopharmaceutical Co., Ltd. Corporate Summary
Table 71. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 72. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporate Summary
Table 74. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 75. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Infectious Bursal Disease Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Infectious Bursal Disease Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Infectious Bursal Disease Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Infectious Bursal Disease Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Infectious Bursal Disease Vaccine Market Opportunities & Trends in Global Market
Table 81. Infectious Bursal Disease Vaccine Market Drivers in Global Market
Table 82. Infectious Bursal Disease Vaccine Market Restraints in Global Market
Table 83. Infectious Bursal Disease Vaccine Raw Materials
Table 84. Infectious Bursal Disease Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Infectious Bursal Disease Vaccine Downstream
Table 86. Infectious Bursal Disease Vaccine Downstream Clients in Global Market
Table 87. Infectious Bursal Disease Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of Infectious Bursal Disease Vaccine in Global Market
Table 2. Top Infectious Bursal Disease Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Infectious Bursal Disease Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Infectious Bursal Disease Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Infectious Bursal Disease Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Infectious Bursal Disease Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Infectious Bursal Disease Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Infectious Bursal Disease Vaccine Product Type
Table 9. List of Global Tier 1 Infectious Bursal Disease Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Bursal Disease Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Infectious Bursal Disease Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Infectious Bursal Disease Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Infectious Bursal Disease Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales, (K Units), 2023-2028
Table 46. Zoetis Corporate Summary
Table 47. Zoetis Infectious Bursal Disease Vaccine Product Offerings
Table 48. Zoetis Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Infectious Bursal Disease Vaccine Product Offerings
Table 51. Merck Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Elanco Corporate Summary
Table 53. Elanco Infectious Bursal Disease Vaccine Product Offerings
Table 54. Elanco Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Boehringer Ingelheim Corporate Summary
Table 56. Boehringer Ingelheim Infectious Bursal Disease Vaccine Product Offerings
Table 57. Boehringer Ingelheim Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Ceva Corporate Summary
Table 59. Ceva Infectious Bursal Disease Vaccine Product Offerings
Table 60. Ceva Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Qingdao Yibang Biological Engineering Co., Ltd. Corporate Summary
Table 62. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 63. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Shandong Lvdu Biological Technology Co., Ltd. Corporate Summary
Table 65. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 66. Shandong Lvdu Biological Technology Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Plyco Bioengineering Co., Ltd. Corporate Summary
Table 68. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 69. Plyco Bioengineering Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Ruipu Biopharmaceutical Co., Ltd. Corporate Summary
Table 71. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 72. Ruipu Biopharmaceutical Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Corporate Summary
Table 74. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Product Offerings
Table 75. Harbin Pharmaceutical Group Biological Vaccine Co., Ltd. Infectious Bursal Disease Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Infectious Bursal Disease Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Infectious Bursal Disease Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Infectious Bursal Disease Vaccine Production by Region, 2017-2022 (K Units)
Table 79. Global Infectious Bursal Disease Vaccine Production by Region, 2023-2028 (K Units)
Table 80. Infectious Bursal Disease Vaccine Market Opportunities & Trends in Global Market
Table 81. Infectious Bursal Disease Vaccine Market Drivers in Global Market
Table 82. Infectious Bursal Disease Vaccine Market Restraints in Global Market
Table 83. Infectious Bursal Disease Vaccine Raw Materials
Table 84. Infectious Bursal Disease Vaccine Raw Materials Suppliers in Global Market
Table 85. Typical Infectious Bursal Disease Vaccine Downstream
Table 86. Infectious Bursal Disease Vaccine Downstream Clients in Global Market
Table 87. Infectious Bursal Disease Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Infectious Bursal Disease Vaccine Segment by Type
Figure 2. Infectious Bursal Disease Vaccine Segment by Application
Figure 3. Global Infectious Bursal Disease Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Bursal Disease Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Bursal Disease Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Infectious Bursal Disease Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Bursal Disease Vaccine Revenue in 2021
Figure 9. By Type - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Infectious Bursal Disease Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Infectious Bursal Disease Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 19. US Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 33. China Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Infectious Bursal Disease Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Infectious Bursal Disease Vaccine by Region, 2021 VS 2028
Figure 50. Infectious Bursal Disease Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Infectious Bursal Disease Vaccine Segment by Type
Figure 2. Infectious Bursal Disease Vaccine Segment by Application
Figure 3. Global Infectious Bursal Disease Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Bursal Disease Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Bursal Disease Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Infectious Bursal Disease Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Infectious Bursal Disease Vaccine Revenue in 2021
Figure 9. By Type - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Infectious Bursal Disease Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Infectious Bursal Disease Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 19. US Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 33. China Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Infectious Bursal Disease Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Infectious Bursal Disease Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Infectious Bursal Disease Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Infectious Bursal Disease Vaccine by Region, 2021 VS 2028
Figure 50. Infectious Bursal Disease Vaccine Industry Value Chain
Figure 51. Marketing Channels
